Shows some of its FDA 510 (k) reforms
The U.S. Food and Drug Administration (FDA), the game drew less controversial elements of the proposed reform), 510 (k notification procedure before they are sold to moderate-risk medical devices. The polarization of the FDA's most plans, including the creation of a new category of class IIb need information to support clinical trials and equivalency provisions that require post-marketing s